Ibrutinib’s Success in CLL Treatment: Supported by Real World Data
Final results are in from the EVIdeNCE study, which analyzed 309 chronic lymphocytic leukemia (CLL) patients [...]
Between Two Scientists: New Types of Data
Today's episode of tHEORetically Speaking is the third installment of Panalgo’s ‘Between Two Scientists’, featuring host Meg Richards, Executive Director of Solutions at Panalgo, who chats with Norstella’s General Manager of RWD, Ted Search, General Manager of RWD at Norstella about new types of unstructured real-world data and the challenges of incorporating them with structured data.
Pain Points Associated with Analyses of Real-World Data Sources: A Survey
To inform an upcoming ISPOR 2024 workshop, David Thompson of Rubidoux Research is fielding a brief survey to solicit [...]
3rd Diversity in Clinical Trials
There has never been a greater time or need than now for pharma to move the needle on making clinical [...]
Can We Trust the Data? The Case for Validation
Real world research has produced recent newsworthy findings on topics as diverse as COVID, mental health, cancer, and dementia. [...]
Advancements and Challenges in Real-World Data and Evidence in Healthcare
Real-world data (RWD) and real-world evidence (RWE) play significant roles in medical product development and regulatory [...]
Shifting the Paradigm to Pragmatic Evidence Generation
By: Richard Gliklich, MD, OM1 & Sonja Wustrack, MPH, OM1 Integrated Evidence Generation Integrated evidence generation (IEG) is a framework [...]
Between Two Scientists: Labeling and Certifying your Varietal Data Blend
This episode of tHEORetically Speaking is the second installment of Panalgo's 'Between Two Scientists', featuring host Meg Richards, Executive Director of Solutions at Panalgo, and Bobby Samuels, General Manager of Privacy Hub at Datavant.
Nearly Half of Americans Affected by COVID-19 Misinformation, Study Finds
Almost half of Americans felt their decisions related to COVID-19 were influenced by misinformation, and 43.7% [...]
Evidation Announces Major Partnership with ‘Our Future Health’ for Multi-Year UK Health Research Program
Evidation, a health-tech company, has announced a significant partnership with Our Future Health, a national health [...]
How AI Can Help Dermatology: Diagnosis, Treatment, Risk, and R&D
The hype around AI is finally translating into real-world value, and we are seeing broader adoption of real-world data in Dermatology. This episode of tHEORetically Speaking features Dr. Stefan Weiss, Managing Director of Dermatology and Dr. Joseph Zabinski, Managing Director of AI and Personalized Medicine at OM1, who discuss the path to personalized medicine and AI-powered clinical decision support in dermatology.
U.S. Men’s Life Expectancy Gap Widens to Largest Since 1996 Amid Public Health Crises and Covid-19 Impact
The life expectancy of men in the U.S. is about six years shorter than women, according [...]
Navigating the Challenges of Real-World Data Management for Improving Patient Outcomes
Real-world data (RWD) and real-world evidence (RWE) can improve patient outcomes by optimizing clinical trials and [...]
FDA Issues Draft Guidance Recognizing the Role of Real-World Evidence in Learning More about Populations Underrepresented in Clinical Trials for Drugs and Biological Products
By: Ulka Campbell, Head of Scientific Strategy, Aetion Of the many potential use cases for real-world data (RWD) [...]
Global Real-World Data Market Forecast to Grow at 14.4% CAGR from 2023 to 2030, Fueled by Increased Demand for Evidence-based Medicine and Technological Advancements
The global real-world data (RWD) market, which encompasses data collected outside of clinical trials, is forecasted to grow at a [...]
Leveraging Real-World Data for Precision Obesity Treatment
Today's episode of tHEORetically speaking features Gary Curhan, Chief Medical Officer and Jessica Paulus, Vice President of Research at OM1, as they answer questions on Leveraging Real-World Data for Precision Obesity Treatment.
Three Considerations to Expand Physicians’ Bandwidth and Improve Real-World Safety Reporting
The ever-expanding field of pharmacovigilance highlights the importance of identifying and tackling problems with real-world safety reporting. Despite this [...]
Hard to Define, Harder to Find Patients: Using AI & Real-World Data to Understand Treatment Resistant Depression
Mental health conditions can take a staggering toll on an individual physically, socially and financially. Many patients languish with [...]
Get to Know R-S-S (Regulatory Scientific and Health Solutions)
Supplier Spotlight® highlights the unique skills and services offered by organizations that are part of our CONNECTED COMMUNITY™. [...]
Finding Value in Linking Real-World Data with Social Determinants of Health
Hear Pamela Landsman-Blumberg and Rick Chapman highlight the importance of SDOH and discuss examples of how claims data and EMR linked with SDOH can inform use cases.
Real-World Data Can Bring Value to Life Sciences Companies Operating in a Value-Based World
The healthcare industry -- from providers and health systems to payers -- is increasingly adopting value-based care practices, which [...]
Podcast Q&A: Designing Causal Inference Studies Using Real-World Data
This podcast segment features the Q&A from HealthCore's December 7, 2022 webinar and features an expert panel including Michael [...]
Podcast Q&A: HEOR for Medical Technologies for the US Healthcare System
This podcast segment features the Q&A from Alira Health's December 14, 2022 webinar and features Deepak Sahu, MBA, MPH [...]
Getting Real About Real-World Data
The terms “Real-World Data” (RWD) and “Real-World Evidence” (RWE) are often thrown around in the life science industry, [...]
Using Real-World Data for Patients with Multiple Sclerosis: A New Machine Learning Model for the Expanded Disability Status Scale (EDSS)
Multiple sclerosis (MS) is a chronic illness in which the body’s immune system attacks myelin, the substance that surrounds [...]
